This Daily Meeting & Webinar is a Physicians Collaborative between APPNA MERIT and Pakistani institutions to discuss updates and lessons learned daily for treatment of acute care or inpatient management of hospitalized patients with Coronavirus infections.
Topic: COVID-19 clinical presentation and management.
Speaker: Sajid Choudhary
APPNA Leadership:
1. Dr. Naheed Usmani, MD (President, APPNA)
2. Dr. Shahid Rafiq, MD (Chair, APPNA MERIT)
3. Danish Bhatti, MD FAAN (Co-Chair APPNA MERIT)
Some questions and comments by participants in this webinar:
1. What kind of pulmonary damage does it cause to affect 02 diffusion exchange problems?
2. Why do the pts with COVID 19 infection have difficulty with I/V hydration inspite of fairly normal LV systolic function?
3. What is the PCR results turnaround time?
4. We do try to keep the lungs dry and go for proning; but how do we deal with hypotension?
5. Any role for convalescent serum?
6. Any role of lab testing after recovery to confer immunity or recovery?
7. Any role of herd immunity?
8. We are given one N95 mask per person and expected to keep reusing it. What is your viewpoint on reusing the N95 mask?
9. Do we need to discourage use of different kinds of facemasks by people that are not infected and create a feel of panic?
10. Should we discourage use of different kinds of facemasks by people that are not infected and create a feel of panic?
11. Is it true that a Pakistani entrepreneur has invented a ventilator of a very low cost?
12. Anyone arriving at the hospital or clinic with gloves or facemask are asked to take of their gloves and mask and take a fresh one if needed in order to prevent infection to come in. Is that helpful in preventing the spread?
13. how do we test for covid19? Antibodies or antigens?
14. I am not sure abt this info that chloroquine enhances alkalinity of endosomes preventing viral survival, any comment?
15. Was is the rational for using hydrozyxhloroquine and azithromycin
16. Is there any evidence that the virus has gone through mutations during its travel from China t US and other countries?
17. On the use of plasma from recovered pts for passive immunity, what I understand from literature that it is for the short time as compared to natural immunity which is for long term. What if the patients exposed to passive immunity do not develop long term immunity against the virus and later become the pool of susceptibles and cases once the pandemic is well over?
18. How’s is his experience with Remdesivir ? does he got patients enrolled as compassionate use is no more allowed.
i can comment on that questions as well regarding mask in ORs use PAPR , as length of contact in directly proportional to higher exposure . Especially in surgeons working in ENT and airway . A paper from stanford highlighted importance
19. comment on hi flow nasal cannula…recommended if in Negative pressure room if possible
The biggest challenge are PUI patients…under investigation patient with baseline hypercarbia…that is a tough one to intubate early. Any comments from other pulmonologist?
19. tocilizumab we have tried in 3 of our patients
France: The BCG was mandatory for school children between 1950 and 2007, and for healthcare professionals between 1947 and 2010. Vaccination is still available for French healthcare professionals and social workers but is now decided on a case by case basis. And France is one of the worst effective nation.
20. What is the role of ACE2 inhibitors .. is it correct that ACE 2 inhibitors are effective to counter COVID 19 ??
21. Is it any role of ACE2 inhibitors in treating COVID 19 ?
22. What are reasons of high mortality in US & European countries than Asians?
23. Any role of Vitamin C, minerals etc
24. What is the False Positive rate in PCR test?
25. Many COVID Patients have been reported presenting with SOB and chest pain, ECGs having Acute changes and raised Troponin too. Should these patients be managed as myocarditis or ACS?
26. If a person gets infected with COVID-19 and gets recovered, is he immune to infection second time with COVID?
27. There was a news about using antibodies from recovered patient . wats the update on that .
